Wednesday, 3 November 2010

Glial activation in the rostroventromedial medulla promotes descending facilitation to mediate inflammatory hypersensitivity

Roberts et al. (2009), Eur J Neurosci
Abstract
Substantial evidence shows that activation of glial cells in the spinal cord may promote central sensitization and pain. Descending facilitation from the rostroventromedial medulla (RVM) is a critical component in the maintenance of chronic pain states, although the precise mechanisms through which facilitation maintains pain are unclear. Here, we investigated the possibility that glial activation in the RVM could promote descending facilitation from the RVM in states of inflammatory pain. Peripheral inflammation was induced with carrageenan injected into the hindpaws of male Sprague-Dawley rats, and behavioral responses to noxious thermal and light tactile stimuli were determined. Microinjection of the glial inhibitors minocycline or fluorocitrate, or of the p38 mitogen-activated protein kinase (MAPK) inhibitor SB 203580, produced a significant and time-related attenuation of behavioral hypersensitivity resulting from hindpaw inflammation. Carrageenan-induced inflammation increased immunolabeling for microglia and astrocytes in the RVM, as well as for phosphorylated p38 MAPK. Phosphorylated p38 MAPK was found in microglia and neurons of the RVM. Inflammation-induced microglial and astrocytic activation in the RVM were attenuated by RVM microinjection of the glial inhibitors. The data show that inflammatory pain is associated with glial activation in the RVM that probably participates in driving descending pain facilitation. These findings reveal a novel site of glial modulation of inflammatory pain.

There is huge scientific evidence for the role of the immune system in pain providing forward routes for new thinking in treatment

Dysfunction of endogenous pain inhibition during exercise with painful muscles in patients with shoulder myalgia & fibromyalgia

Lannersten & Kosek
Pain 151 (2010) 77-86

The aim of this study was to investigate how exercise influenced endogenous pain modulation in healthy controls, shoulder myalgia patients and fibromyalgia (FM) patients. Twenty-one healthy subjects, 20 shoulder myalgia patients and 20 FM patients, all females, participated. They performed standardized static contractions, that is, outward shoulder rotation (m. infraspinatus) and knee extension (m. quadriceps). Pressure pain thresholds (PPTs) were determined bilaterally at m. infraspinatus and m. quadriceps. During contractions PPTs were assessed at the contracting muscle, the resting homologous contralateral muscle and contralaterally at a distant site (m. infraspinatus during contraction of m. quadriceps and vice versa). Myalgia patients had lower PPTs compared to healthy controls at m. infraspinatus bilaterally (p<0.01), but not at m. quadriceps. FM patients had lower PPTs at all sites compared to healthy controls (p<0.001) and myalgia patients (p<0.001). During contraction of m. infraspinatus PPTs increased compared to baseline at the end of contraction in healthy controls (all sites: p<0.003), but not in myalgia or FM patients. During contraction of m. quadriceps PPTs increased compared to baseline at the end of contraction in healthy controls (all sites: p<0.001) and myalgia patients (all sites: p<0.02), but not in FM patients. In conclusion, we found a normal activation of endogenous pain regulatory mechanisms in myalgia patients during contraction of the non-afflicted m. quadriceps, but a lack of pain inhibition during contraction of the painful m. infraspinatus. FM patients failed to activate their pain inhibitory mechanisms during all contractions.

This is an intreating study that suggests to exercise remote areas of the body can have beneficial effects for myalgia by having a pain relieving effect whereas in fibromyalgia this can aggravate if the intensity is too great. For the latter, a progressive programme built from an individualised baseline would be more beneficial.

Tuesday, 2 November 2010

New Specialist Pain Physio Website

The new website for The Specialist Pain Physio Clinics is now live with information about our services, a regular blog, details about pain and the latest research.
www.specialistpainphysio.com

Wednesday, 20 October 2010

The human glucocorticoid receptor: molecular basis of biologic function

Abstract:
The characterization of the subfamily of steroid hormone receptors has enhanced our understanding of how a set of hormonally derived lipophilic ligands controls cellular and molecular functions to influence development and help achieve homeostasis. The glucocorticoid receptor (GR), the first member of this subfamily, is a ubiquitously expressed intracellular protein, which functions as a ligand-dependent transcription factor that regulates the expression of glucocorticoid-responsive genes. The effector domains of the GR mediate transcriptional activation by recruiting coregulatory multi-subunit complexes that remodel chromatin, target initiation sites, and stabilize the RNA-polymerase II machinery for repeated rounds of transcription of target genes. This review summarizes the basic aspects of the structure and actions of the human (h) GR, and the molecular basis of its biologic functions.
Steroids (2010), 75(1):1-12

Stress & disorders of the stress system

Chrousos (2009). An excellent article; abstract below:
All organisms must maintain a complex dynamic equilibrium, or homeostasis, which is constantly challenged by internal or external adverse forces termed stressors. Stress occurs when homeostasis is threatened or perceived to be so; homeostasis is re-established by various physiological and behavioral adaptive responses. Neuroendocrine hormones have major roles in the regulation of both basal homeostasis and responses to threats, and are involved in the pathogenesis of diseases characterized by dyshomeostasis or cacostasis. The stress response is mediated by the stress system, partly located in the central nervous system and partly in peripheral organs. The central, greatly interconnected effectors of this system include the hypothalamic hormones arginine vasopressin, corticotropin-releasing hormone and pro-opiomelanocortin-derived peptides, and the locus ceruleus and autonomic norepinephrine centers in the brainstem. Targets of these effectors include the executive and/or cognitive, reward and fear systems, the wake-sleep centers of the brain, the growth, reproductive and thyroid hormone axes, and the gastrointestinal, cardiorespiratory, metabolic, and immune systems. Optimal basal activity and responsiveness of the stress system is essential for a sense of well-being, successful performance of tasks, and appropriate social interactions. By contrast, excessive or inadequate basal activity and responsiveness of this system might impair development, growth and body composition, and lead to a host of behavioral and somatic pathological conditions. Nat Rev Endocrinol 5(7):374-81

Neuroendocrinology of post-traumatic stress disorder

Pervanidou & Chrousos (2010)
Abstract: Dysregulation of the stress system, including the hypothalamic-pituitary-adrenal (HPA) axis and the locus caeruleus/norepinephrine-sympathetic nervous system (SNS), is involved in the pathophysiology of post-traumatic stress disorder (PTSD), an anxiety disorder that develops after exposure to traumatic life events. Neuroendocrine studies in individuals with PTSD have demonstrated elevated basal cerebrospinal fluid corticotropin-releasing hormone concentrations and contradictory results from peripheral measurements, exhibiting low 24 hours excretion of urinary free cortisol, low or normal circulating cortisol levels or even high plasma cortisol levels. The direction of HPA axis activity (hyper-/or hypo-activation), as evidenced by peripheral cortisol measures, may depend on variables such as genetic vulnerability and epigenetic changes, age and developmental stage of the individual, type and chronicity of trauma, co-morbid depression or other psychopathology, alcohol or other drug abuse and time since the traumatic experience. On the other hand, peripheral biomarkers of the SNS activity are more consistent, showing increased 24h urinary or plasma catecholamines in PTSD patients compared to control individuals. Chronically disturbed hormones in PTSD may contribute to brain changes and further emotional and behavior symptoms and disorders, as well as to an increased cardiometabolic risk. Prog Brain Res. 182:149-60

Sunday, 17 October 2010

Positve mood & thinking - the benefits

Ask most people and of course they would agree that positive thinking is going to make life better. Asking people how often they spend time in a positive mood can be an interesting self-reflective exercise. It all seems quite obvious really, but it does seem that in many cases negative thinking and rumination prevails. An increasingly popular method of dealing with this way of living is the Buddhist approach of mindfulness. Maintaining awareness of the present moment without judgement is the essence of this practice underpinned by regular meditation. The argument is that we spend far too much time pondering on the past (it's too late, nothing can be done about that) or the future (that has not happened yet) and not enough in appreciating the now. The mind is blamed for taking us off into past events or into scenarios that have not even occurred (e.g. the argument that you are going to have with the boss). How about reducing this mind activity?

Research shows us that positive moods increase our visual attention aiding the collection of information about the world around us, improves creativity, social skills, ability to deal with criticism, our verbal reasoning and problem-solving ability. Practicing postive thinking regualarly seems to build our resilience and ability to gain benefit. There is likely to be a genetic disposition (accounting for around 50% of the variability) but we also have the ability to change through learning and adaptation.

It is likely that personality type will affect the way in which you create your positive mood. Therefore trying different methods is best. Some ideas to change your mood for the better include challenging your negative thoughts (cognitive restructuring), meditation and developing relationships with family and friends.

Those suffering pain often present with a negative mindset that is understandable. Working to restructure the beliefs and thoughts and subsequently how the pain is interpreted is an excellent way of improving control. At Specialist Pain Physio we work closely with patients to lessen the impact of pain and suffering with techniques that increase positivity for the aforementioned reasons. Additionally it has a good effect upon the immune system that is very much involved in pain. It takes time and effort as part of the treatment and rehabilitation programme for pain, chronic pain & injury.

Reading
Be Happy, Dan Jones. New Scientist 25th Sept 2010